
Best international large-cap healthcare stocks to invest in 2026
International large-cap healthcare stocks give investors exposure to established pharmaceutical and biopharmaceutical businesses outside the United States. Are you looking for proven international drug developers combining niche leadership with strengthening financial performance? Orion Oyj develops and manufactures human and veterinary medicines and active pharmaceutical ingredients, selling products in more than one hundred countries through its own network and partners. Otsuka Holdings coordinates pharmaceuticals, nutraceuticals, and consumer health businesses with core franchises in central nervous system, renal, and oncology treatments. Swedish Orphan Biovitrum develops and provides treatments for rare diseases, serving patients with limited options across multiple orphan drug categories. International large-cap healthcare stocks combine established European and Japanese franchises with focused portfolios in pharmaceuticals and rare disease treatments. These are among the best international large-cap healthcare stocks for 2026.
Tags: stocks







